Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Rong Tao
Extranodal natural killer/T-cell lymphoma, nasal type, is a rare subtype of non-Hodgkin lymphoma with relatively high incidence in China. L-asparaginase based chemotherapy are widely used with Chinese patients and has been reported to improve overall response and prolonged the long-term survival in some clinical trials with very limited patients. However, most patients were treated out of clinical trials in China. Therefore the real incidence of adverse events and treatment outcomes are largely unknown. This study is designed to evaluate the incidence of adverse events and treatment outcomes by social media-based (www.house086.com, www.wechat.com) self-report from patients who are treated out of clinical trials.
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Pathological diagnosis of extranodal natural killer/T-cell lymphoma, nasal type based on WHO 2008 classification of tumors of haematopoietic and lymphoid tissue.
Treated with at least one cycle of L-asparaginas or Pegaspargase based chemotherapy.
Signed Informed consent.
You may not be if
patients who are enrolled in any other clinical trials.
Relapsed patients who were initially treated with non-L-asparaginas or non-pegaspargase based regimens.